CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-20 | MARCUS JOEL S Director | Sale | −5,000 | $18.76 | $94K | 324,700 |
| 2020-05-19 | MARCUS JOEL S Director | Sale | −7,809 | $18.40 | $144K | 329,700 |
| 2020-05-18 | MARCUS JOEL S Director | Sale | −15,000 | $19.15 | $287K | 337,509 |
| 2020-05-08 | Lucchino David L. President and CEO | Sale | −10,478 | $18.18 | $190K | 433,800 |
| 2020-05-06 | Loose Christopher R. Chief Scientific Officer | Sale | −3,946 | $16.23 | $64K | 192,336 |
| 2020-05-06 | Loose Christopher R. Chief Scientific Officer | Sale | −554 | $16.68 | $9K | 191,782 |
| 2020-05-05 | Lucchino David L. President and CEO | Sale | −5,239 | $16.19 | $85K | 444,278 |
| 2020-05-01 | Lucchino David L. President and CEO | Sale | −5,236 | $15.28 | $80K | 449,517 |
| 2020-04-24 | Lucchino David L. President and CEO | Sale | −729 | $16.35 | $12K | 454,753 |
| 2020-04-23 | Lucchino David L. President and CEO | Sale | −1,410 | $16.08 | $23K | 455,482 |
| 2020-04-22 | Loose Christopher R. Chief Scientific Officer | Sale | −4,500 | $14.84 | $67K | 196,282 |
| 2020-04-17 | Lucchino David L. President and CEO | Sale | −3,100 | $16.00 | $50K | 456,892 |
| 2020-04-15 | Lucchino David L. President and CEO | Sale | −5,236 | $15.13 | $79K | 459,992 |
| 2020-04-08 | Loose Christopher R. Chief Scientific Officer | Sale | −4,500 | $14.99 | $67K | 200,782 |
| 2020-02-12 | Arnold Wendy S Chief People Officer | Grant or award · Stock Option | +130,000 | 130,000 | ||
| 2020-02-12 | Mitrano Richard J. VP Finance & Operations | Grant or award · Stock Option | +18,000 | 18,000 | ||
| 2020-02-12 | Loose Christopher R. Chief Scientific Officer | Grant or award · Stock Option | +57,500 | 57,500 | ||
| 2020-02-12 | Hilt Dana Charles Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2020-02-12 | Lucchino David L. President and CEO | Grant or award · Stock Option | +242,500 | 242,500 | ||
| 2020-02-12 | LeBel Carl Chief Development Officer | Grant or award · Stock Option | +57,500 | 57,500 |
Page 31 of 34 · 670 trades